• Medarex and Northwest Biotherapeutics Announce Alliance To Develop New Cancer Therapies
  Northwest Biotherapeutics intends to initially contribute four of its existing cancer related targets, and over the next several years, NWBio will contribute four additional, yet to be determined, cancer targets to the alliance's fully human antibody-base
  in Public bookmarks with antibodies biotechnology biotherapeutics biotherapy brain cancer company dcvax defense fight immune immunotherapies medarex news northwest prostate system treatment tumors vaccine by 3 users

antibodies from all users